Clinical trial
Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After…
NCT00280514 · Medical University of Vienna, Other · Completed
Key facts
| NCT number | NCT00280514 |
|---|---|
| Title | Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration |
| Official title | Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration |
| Lead sponsor | Medical University of Vienna, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Abscess, Cysts |
| Intervention type | Drug |
| Interventions | cefpirome and moxifloxacin administration |
| Enrollment | 20 |
| Start date | Jan 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Jan 23, 2006 |
| Last update posted | Aug 4, 2010 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: